Physician profile
Robert S Consor
NPI 1538154646
$1,704.68
in general payments reported to CMS, 2019-2025
16 companies · $543 in 2025
The $543 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $62.19 · 2023: $350 · 2024: $390 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.14 | 2023-2025 | Lumigan, Alphagan P, Durysta |
| Bausch & Lomb Americas INC. | $297.78 | 2023-2025 | Infuse, Vyzulta, Miebo |
| Biotissue Holdings INC. | $173.18 | 2024-2025 | |
| Coopervision INC. | $143.21 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $123.66 | 2019 | |
| Maculogix, INC. | $121.72 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $87.72 | 2024-2025 | Xdemvy |
| Ani Pharmaceuticals, INC. | $71.74 | 2023-2024 | Purified Cortrophin Gel |
| Alcon Vision LLC | $65.49 | 2023-2025 | Rocklatan, Clareon |
| Thea Pharma INC. | $60.27 | 2023-2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $42.40 | 2025 | |
| Dompe US, INC. | $27.13 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $21.92 | 2024 | Callisto Eye |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tearlab Corp | $15.89 | 2023 | Tearlab Osmolarity System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $14.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Consor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.